enVVeno Medical Corporation Common Stock
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is NVNO moving today?
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
NVNO overview
Related filings and maps
Congress activity in NVNO
No receipt-qualified Congressional disclosure is present for NVNO in the cached public ledger.
NVNO contract awards, year to date.
Public federal awards linked to this ticker.
NVNO lobbying filings, year to date.
Registered lobbying filings matched to enVVeno Medical Corporation Common Stock.